Skip to main content

Find Clinical Trials

Home
Conditions
Esophagus Cancer

Clinical trial condition

Esophagus Cancer

Explore clinical trials studying Esophagus Cancer. Study availability and eligibility vary by location and protocol.

77 public trials 25 recruiting studies

Refine in advanced search Browse all conditions

Esophagus Cancer trial results

Not Yet Recruiting

Tislelizumab Combined With Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma Followed by CRT or Surgery

NCT07046221

Conditions: Digestive System Diseases, Digestive System Neoplasms, Esophageal Diseases, +7 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Tislelizumab Combined With Chemotherapy for the Perioperative Treatment of Esophageal Squamous Carcinoma

NCT07019181

Conditions: Digestive System Diseases, Digestive System Neoplasms, Esophageal Diseases, +7 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Tislelizumab as Single-Agent Neoadjuvant Immunotherapy in Resectable Esophageal Squamous Cell Carcinoma

NCT06692270

Conditions: Digestive System Diseases, Digestive System Neoplasms, Esophageal Diseases, +7 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Comparison of Long-term Survival and Quality of Life After Minimally Invasive Esophagectomy Versus Open Esophagectomy

NCT06147180

Conditions: Digestive System Diseases, Digestive System Neoplasms, Esophageal Diseases, +10 more
Locations: Qilu Hospital of Shandong University Ji'nan, Shandong, China

View Trial Details

Completed

Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors

NCT04902872

Conditions: Adnexal Diseases, Appendiceal Neoplasms, Appendix Cancer, +61 more
Locations: Yale Cancer Center New Haven, Connecticut, United States

NEXT Oncology Austin, Texas, United States

MD Anderson Cancer Center Houston, Texas, United States

NEXT Oncology San Antonio, Texas, United States

View Trial Details

Completed

Association of Radiochemotherapy and Immunotherapy for the Treatment of Unresectable Oesophageal caNcer

NCT03777813

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Squamous Cell, +14 more
Locations: Centre Oscar Lambret, CLCC UNICANCER Lille, France

Hôpital Saint Louis, APHP Paris, France

Hôpital Haut-Lévêque Pessac, France

Centre Hospitalier Universitaire Poitiers, France

View Trial Details

Completed

Enhanced Assistance During Radiotherapy for Unmet Essential Needs

NCT06582849

Conditions: Adnexal Diseases, Anal Cancer, Anus Diseases, +117 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Completed

Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory Solid Tumor Malignancies

NCT03199586

Conditions: Adnexal Diseases, Advanced or Metastatic Treatment-refractory Solid Tumor Malignancies, Breast Cancer, +51 more
Locations: HonorHealth Research Institute Scottsdale, Arizona, United States

City of Hope National Medical Center Duarte, California, United States

Memorial Sloan Kettering Hospital New York, United States

View Trial Details

Completed

Study of PD-1 Antibody Combined With Chemoradiotherapy in Oligometastatic Esophageal Cancer

NCT04821765

Conditions: Chemoradiotherapy, Digestive System Diseases, Digestive System Neoplasms, +10 more
Locations: Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC) Beijing, Beijing Municipality, China

Department 4th of Radiation Oncology, Anyang Cancer Hospital Anyang, Henan, China

View Trial Details

Completed

A Study of PET Scans With the Radioactive Tracer 18F-BMS-986229 in Patients With Esophageal, Stomach, or Gastroesophageal Junction Cancer

NCT04161781

Conditions: Digestive System Diseases, Digestive System Neoplasms, Esophageal Cancer, +15 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details